$亚盛医药-B(06855)$ 网页链接
王教授發明的第一隻藥(不屬於6855),只是專利收費暫時己有8.66億美金,而亞盛有他發明的數隻藥,市值不足14億美元。
The American Chemical Society (ACS) named Shaomeng Wang, PhD, its 2020 Division of Medicinal Chemistry Award recipient and newest Hall of Fame inductee. Prof. Wang will present his award lecture at the ACS MEDI Virtual Award Session on June 29, 2021
The first compound invented in his laboratory at the University of Michigan and advanced into clinical development, xevinapant (Debio 1143/AT-406/SM-406), is currently in Phase 3 registration trial for the treatment of head-neck cancer and was recently licensed from Debiopharm to Merck KGaA for $229 million upfront and up to $866 million in milestones and royalty payments.